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Australia has one of the highest melanoma incidence rates worldwide.1 The prognosis of localised 
melanoma is largely dependent on tumour 
thickness, where thin (<1 mm) melanomas 
are potentially curable with surgical excision 
and have 20-year survival rates as high as 96% 
in Queensland.2,3. In contrast, localised thick 
(>4 mm) melanomas are associated with a 
39% 10-year survival rate.2
The diagnosis of cancer can cause significant 
psychological distress and reduce quality 
of life of cancer patients and their family 
members.4 Psychological distress appears 
to be higher in patients whose disease is at 
high risk of progression and is associated with 
poorer prognosis.5-7 We recently demonstrated 
that a substantial proportion of newly 
diagnosed patients with locally invasive 
primary melanoma have unmet needs, 
particularly for information on melanoma 
recurrence, prognosis and psychosocial 
supports.5 Patients with primary melanoma 
also experienced significantly lower emotional 
wellbeing than general population norms.5 
Accessing health information, counselling 
services or community support services 
may enhance patients’ understanding of 
their disease and improve psychosocial 
wellbeing.8-10 In addition to psychological 
support, melanoma patients may require 
physical therapies to cope with cancer fatigue 
and/or physical symptoms experienced 
after lymph node biopsies or dissections.11,12 
A multidisciplinary approach to patient’s 
psychosocial and physical needs is seen as 
essential to cancer care.13
Many general and melanoma-specific 
support services are available to Queensland 
patients, ranging from standard primary 
care, allied health and mental health services 
to internet- or phone-based or group 
counselling services.14 Patients in regional 
and remote areas within Australia may have 
limited access to some of these services due 
to barriers such as the need to travel large 
distances, financial costs and limited internet 
access.15 Furthermore patients in regional 
and remote areas in Australia have poorer 
melanoma survival rates and thus they may 
be particularly vulnerable to having elevated 
supportive care needs associated with their 
poorer prognosis.16,17 It is unknown however 
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Abstract
Objective: To characterise use of support services in patients diagnosed with high-risk primary 
melanoma by their location of residence. 
Methods: In a cross-sectional study of 787 patients with histologically-confirmed clinical 
stage 1B-2 melanoma, we estimated odds ratios (ORs) using regression models to assess the 
association of support service use with residence in rural, regional or urban areas. We also 
evaluated demographic and clinical correlates of support service use. 
Results: Among 113 rural patients, 33 (29%) used support services around time of diagnosis 
compared to 88 (39%) of 224 regional participants and 164 of 448 (37%) urban participants. 
Regional participants more commonly used support services compared to rural participants 
(OR 1.84; CI 1.09-3.10), but there was no association with urban versus rural residence (OR 1.32; 
CI 0.82-2.13). As well, females (OR 1.58; CI 1.15-2.18), those <65 years (OR 1.96; CI 1.42-2.71), or 
with higher education (OR 2.30; CI 1.53-3.44), or those with T-stage 4B (OR 2.69; CI 1.36-5.32) 
were more likely to use support services than other patients.
Conclusion: Use of support services is lower among rural patients and other sub-groups of 
primary melanoma patients who have poorer prognoses than others. 
Implications for public health: Appropriate triage to support services is required for rural and 
other vulnerable patient groups to ensure optimal patient care. 
Key words: melanoma , support services , remoteness of residence , Queensland, high-risk 
patients
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whether support service use differs among 
melanoma patients according to their 
geographic location. 
We aimed to determine whether use of 
support services differs for Queensland 
patients with primary melanomas at high 
risk of progression, depending on location of 
residence (urban, regional or rural). We also 
identified and adjusted for other correlates of 
support use in this cohort. 
Methods
Study population 
Participants were recruited prospectively 
between October 2010 and October 2014 
from a variety of specialist public hospital 
clinics, private practices of surgeons 
associated with the participating public 
hospitals, and through the three main private 
pathology services in Queensland. The public 
hospitals recruiting eligible patients included 
Princess Alexandra Hospital, Royal Brisbane 
and Women’s Hospital, Nambour General 
Hospital and Townsville General Hospital. 
Participants were required to have a 
histologically-confirmed new diagnosis of 
stage 1B or 2 cutaneous melanoma, be aged 
17 years or older, and have the capacity to 
complete the study questionnaire. Eligible 
patients identified through clinics were 
invited to participate by their treating 
doctors (or by study personnel with doctor’s 
permission) and received study information, 
consent form and a questionnaire. Laboratory 
pathologists identified patients and 
included a standard note on eligible patients’ 
histopathology reports, which informed 
treating doctors about the study and asked 
doctors to inform the pathological company 
if their patients should not be contacted. 
Patients for whom no objection was raised 
within two weeks were sent information 
about the study with request for permission 
to release their details to study personnel. 
Those who agreed were contacted and 
written consent was obtained from all 
participants. The study was approved by the 
Human Research Ethics Committees of the 
Metro South Hospital, the Health Service of 
the Princess Alexandra Hospital (HREC/11/
QPAH/470 [Metro South]: 12/10/2010) 
and the QIMR Berghofer Medical Research 
Institute (P1305 [QIMR]: 2/9/2010). 
Data collection 
Personal details including previous 
melanoma history (yes/ no), skin examination 
history (never/every few years/at least yearly) 
and use of sunglasses, hat, sunscreen and 
protective clothing (each classified as never/
sometimes/mostly), were collected for each 
participant at recruitment with a standard 
self-completed questionnaire. Histology 
reports were obtained for all self-reported 
previous melanomas. Socioeconomic factors 
ascertained via the questionnaire included 
employment status (employed/unemployed/
retired), relationship status (partner/no 
partner) and highest level of education (less 
than year 12/technical college or diploma/
University). Details of all primary melanomas 
were extracted from histopathology reports 
including thickness (mm) and presence of 
ulceration (yes/no) or mitosis (per mm2). 
Pathology reports also provided information 
on the specialty of the doctor who performed 
the diagnostic biopsy, the time from biopsy to 
surgical treatment and public versus private 
health sector use. Clinical and tumour (T) 
stages were classified in accordance with the 
2009 American Joint Committee on Cancer 
(AJCC) Melanoma Staging system.2 
Patients’ use of support services in relation 
to their melanoma diagnosis, treatment 
or recovery was indicated on a tick-box 
list on the self-completed questionnaire 
(Supplementary Figure 1, available online). 
In order to reflect modalities of support 
service delivery, services were grouped into 
either: 1) Health providers: where support 
or counselling was provided by a doctor 
or psychiatrist, psychologist, social worker, 
mental health care team, physiotherapist, 
community health nurse, exercise 
physiologist, dietician, pain specialist or 
respite care; 2) Information services: written 
(information sheet), phone (cancer helpline, 
tele-based cancer counselling) or internet-
based (internet information, internet-based 
support group); or 3) Community support 
services: peer support or community groups 
(including community-based support groups, 
relaxation/meditation class and education 
program/workshop). 
Data analysis 
Each patient’s place of residence was 
categorised using the Australian Statistical 
Geographical Classification- Remoteness Area 
(2001) (ASGC-RA). Postcodes were classified 
as major city (urban), inner regional and rural 
(the combination of outer regional, remote or 
very remote). Sun protection behaviours were 
combined into a summary score.
Chi-square, t-test and ANOVA tests were used 
to determine if demographic, behavioural or 
clinical factors of interest or use of support 
services were significantly different by 
location of residence, classified as urban, 
inner regional and rural. Logistic regression 
models were used to estimate odds ratios 
as a measure of the association between 
support service use and location of residence 
while adjusting for known prognostic 
factors (age, sex and tumour stage) and 
other confounding factors (education and 
employment) (Supplementary Table 1, 
available online). Logistic regression models 
were also used to evaluate associations 
with demographic (age, sex, education) 
and clinical (tumour stage at diagnosis) 
factors and support service use. All statistical 
analyses were performed using SAS software 
version 9.4.
Results
Of the 1,254 invited patients, 825 (66%) 
consented to take part. A further 38 were 
found to be ineligible after consent, leaving 
787 study participants. The mean age at 
diagnosis was 62 years, 57% of participants 
were male, and 21% had a histologically 
confirmed past history of melanoma (Table 
1). The study cohort showed no significant 
differences in age or sex distributions when 
compared with total number of cases aged 
less than 80 years diagnosed in Queensland 
within the study period as recorded by the 
Cancer Registry.18
Rural and inner regional participants were 
less likely to have university degrees (p=0.03), 
and inner regional participants were more 
commonly retirees (p=0.03) (Table 1). 
Rural participants were less likely to report 
receiving at least yearly skin examinations 
and they more commonly reported no past 
history of a skin check compared to urban 
and inner regional participants (p=0.006) 
(Table 1). The specialty of the medical 
practitioner who diagnosed the primary 
melanoma, differed by remoteness of 
residence. General Practitioners (GPs) more 
commonly diagnosed melanomas in rural and 
inner regional areas compared to urban areas 
(70% rural; 68% inner regional; 55% urban). 
GPs working in specialised skin cancer clinics 
more commonly diagnosed melanomas in 
urban areas (23% urban versus 13% in rural 
areas) and dermatologists diagnosed 13% 
of melanomas in urban areas, but only 4% 
in rural areas (p<0.001) (Table 1). Time from 
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biopsy to follow-up surgery increased with 
distance from urban areas (urban: 24 days, 
inner regional: 28 days and rural: 33 days) 
(Table 1). 
A total of 37% of participants reported use of 
support services in relation to their melanoma 
around the time of diagnosis. Overall, the 
proportion who used at least one support 
service was lower in rural areas (29%) than in 
regional (39%) or urban areas (37%) (p=0.09) 
(Table 2). Across the state, participants 
most commonly sought information-based 
support, with 22% of participants sourcing 
information from the internet, 7% obtaining 
written information and 1% receiving 
information via the phone. Health providers 
and community support services were used 
by 17% and 13% of participants respectively. 
With the exception of peer support, where 
rurality was associated with less peer support 
use (p=0.01), no differences in specific types 
of support use were detected by geographic 
location (Table 2). 
After adjustment for prognostic and 
confounding variables patients residing in 
regional areas compared to those in rural 
areas were significantly more likely to use 
support services (OR 1.84, 95% CI 1.09-
3.10) but there was no association with 
urban residence (Table 3). Sex, age, level of 
education, and melanoma T-stage were also 
associated with use of at least one support 
service. Females were more likely to use 
support services than males (OR 1.58, 95% CI 
1.15-2.18) and participants under the age of 
65 were twice as likely as older participants 
to use support services (OR 1.96, 95% CI 1.42-
2.71) (Table 3). Those with a university degree 
(OR 2.30, 95% CI 1.53-3.44) or a diploma 
or trade (OR 1.43, 95% CI 1.00-2.06) were 
more likely to have used a support service 
compared with participants who reported 
grade 12 high school or less as their highest 
level of education. Participants with most 
advanced T-stage (4B) were more likely to use 
support services than earliest stage (1B/2A) 
patients (OR 2.69, 95% CI 1.36-5.32). 
Discussion
We found differences in socioeconomic status 
and clinical features of melanoma patients 
in urban, regional and rural areas within 
Queensland. A greater proportion of rural 
and regional patients were socioeconomically 
disadvantaged and had less frequent skin 
checks. Use of support services differed by 
location of residence, whereby participants 
Table 1: Demographic, behavioural and clinical characteristics of cohort by location of residence using the ASCG-RA 
classification.
Overall  
(n=787)
Urban (major city) 
(n=450, 57%)
Inner regional 
(n=224, 29%)
Rural (Outer 
regional/ remote/ 
very remote) 
(n=113, 14%)
p-value
n (%) n (%) n (%) n (%)
Sex 
 Male
 Female 
447 (57)
340 (43)
252 (56)
198 (44)
127 (57)
97 (43)
68 (60)
45 (40)
0.7a
Age (years)
 Mean (SD) 62 (14) 61 (14) 64 (13) 60 (14) 0.052b
Relationship status 
 No partner 
 Partner
199 (25)
586 (75)
117 (26)
333 (74)
54 (24)
169 (76)
28 (25)
84 (75)
0.9a
Education 
 High school or less
 Trade/ diploma
 University 
403 (51)
228 (29)
155 (20)
221 (49)
122 (27)
106 (24)
123 (55)
69 (31)
32 (14)
59 (52)
37 (33)
17 (15)
0.035a
Paid Employment 
 Yes 
 No 
 Retired
339 (45)
53 (7)
366 (48)
212 (48)
34 (8)
193 (44)
73 (34)
12 (6)
127 (60)
54 (50)
7 (7)
46 (43)
0.003a
Sun protection behaviours
 Never 
 Sometimes
 Mostly
125 (16)
427 (54)
235 (29)
70 (16)
250 (56)
130 (29)
39 (17)
121 (54)
64 (29)
16 (14)
56 (50)
41 (36)
0.6a
Skin check by doctor
 Never
 Every few years 
 At least yearly 
153 (20)
236 (31)
380 (49)
75 (17)
144 (33)
222 (50)
44 (20)
59 (27)
117 (53)
34 (31)
33 (31)
41 (38)
0.006a
Past history of melanoma 164 (21) 102 (23) 42 (19) 20 (18) 0.3a
Qualification of biopsy Doctor
 GP
 GP- skin clinic
 General Surgeon 
 Plastic Surgeon 
 Dermatologist
474 (61)
159 (20)
27 (3)
41 (5)
79 (10)
245 (55)
101 (23)
10 (2)
33 (7)
60 (13)
150 (68)
43 (19)
11 (5)
4 (2)
14 (6)
79 (70)
15 (13)
6 (5)
4 (4)
5 (4)
<0.001a
Time from biopsy to surgery (days)
 Mean (SD) 27 (21) 24 (16) 28 (20) 33 (35) 0.0006b
Time from biopsy to questionnaire (days)
 Mean (SD) 40 (25) 37 (23) 44 (27) 43 (23) 0.002b
Health sector
 Public 
 Private 
351 (45)
436 (55)
201 (45)
249 (55)
107 (48)
117 (52)
43 (38)
70 (61)
0.2a
Thickness 
 <1 mm
 1-2 mm
 2-4 mm
 >4 mm
206 (26)
334 (43)
176 (22)
69 (9)
127 (28)
196 (44)
89 (20)
36 (8)
49 (22)
89 (40)
62 (27)
24 (11)
30 (27)
49 (43)
25 (22)
9 (8)
0.2a
T-stage 
 1B/2A
 2B/3A
 3B/4A
 4B
465 (60)
193 (25)
87 (11)
40 (5)
281 (63)
108 (24)
35 (8)
24 (5)
120 (54)
52 (23)
38 (17)
14 (6)
64 (57)
33 (29)
14 (12)
2 (2)
0.006a
SLNB 
 Negative 
 Positive 
222 (85)
38 (15)
110 (82)
24 (18)
63 (89)
71 (11)
49 (89)
6 (11) 
0.3a
a: Results of chi-squared test 
b: Results of ANOVA test 
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Fewer rural participants used support services 
after their melanoma diagnosis, treatment 
and during recovery, compared with urban 
and regional participants. In particular rural 
participants were less likely to use community 
support. This may reflect cultural attitudes 
towards group supports, the barrier of 
distance and/or lack of availability of such 
services. The only support service favoured by 
rural participants was telephone counselling/
information, although this subgroup analysis 
was not sufficiently powered to demonstrate 
a significant association. Our study also 
demonstrates that females, younger patients 
and those with higher education are more 
commonly accessing support services. 
Overall within our study around a third of 
participants utilised support services and the 
most commonly accessed were the internet 
(to obtain information about the disease) and 
counselling by doctors. Structured support 
groups and programs are effective at meeting 
patient’s needs for information, emotional 
and practical support and have been shown 
to improve emotional wellbeing.8,9,27 Use 
of structured support groups is generally 
suboptimal amongst cancer patients and we 
also demonstrate poor uptake of support 
group use within our cohort (2%).27 Hence 
facilitating uptake of support service use 
in these patients may promote wellbeing.27 
Barriers to accessing services may consist 
of patient factors (lack of knowledge, 
socioeconomic limitations, etc) and health 
system factors (inequitable distribution of 
services and service providers).28-30 Patients 
from rural communities may be further 
disadvantaged due to lack of infrastructure 
development, cost pressures associated 
with distance and location, and longer travel 
times15,19 but despite these limitations, type of 
support service used did not differ by location 
Table 2: Use of health, information and community services by location of residence using the ASCG-RA 
classification. 
Support service use Urban  
n (%)
Inner regional  
n (%)
Rural 
n (%)
p-value 
Any 164 (37) 88 (39) 33 (29) 0.09
Health provider
 Counselling provided by doctor 
 Allied health provider
55 (12)
23 (5)
29 (13)
13 (6)
10 (9)
5 (4)
0.5
0.9
Information 
 Internet resources 
 Phone resources
 Written information
99 (22)
6 (1)
33 (7)
45 (20)
1 (0.5)
18 (8)
22 (19)
2 (2)
8 (7)
0.7
0.5
0.9
Community support 
 Peers
 Community groups 
43 (10)
13 (3)
11 (5)
4 (2)
3 (3)
0 (0)
0.01
0.1
Table 3: Factors associated with use of support services. 
Use of health service 
n (%)
OR adjusteda
OR (95% CI)
OR adjustedb 
OR (95% CI) 
Sex 
 Male 
 Female 
142 (32)
143 (42)
1.00 (Ref)
1.53 (1.13-2.08)
1.00 (Ref)
1.58 (1.15-2.18)
Age (years) 
 >65
 <65 
106 (28)
179 (44)
1.00 (Ref)
2.03 (1.49-2.75)
1.00 (Ref)
1.96 (1.42-2.71)
Education 
 High school or less
 Trade/ diploma
 University
118 (29)
88 (39)
78 (50)
1.0 (Ref)
1.44 (1.00-2.06)
2.29 (1.53-3.42)
1.00 (Ref)
1.43 (1.00-2.06)
2.30 (1.53-3.44)
T-stage 
 Stage 1B/2A
 Stage 2B/3A
 Stage 3B/4A
 Stage 4B
169 (37)
64 (33)
30 (35)
22 (55)
1.00 (Ref)
0.98 (0.68-1.42)
1.17 (0.71-1.93)
2.68 (1.37-5.22)
1.00 (Ref)
1.04 (0.71-1.52)
1.21 (0.72-2.04)
2.69 (1.36-5.32)
Location of residence
 Rural 
 Regional 
 Urban
33 (29)
88 (39)
164 (37)
1.00(Ref)
1.83 (1.08-3.08)
1.33 (0.83-2.15)
1.00(Ref)
1.84 (1.09-3.10)
1.32 (0.82-2.13)
a: Adjusted for age, sex, melanoma T-stage 
b: Adjusted for age, sex, melanoma T-stage, employment and education
residing in regional areas more commonly 
utilised support services compared with 
those residing in rural areas. No statistically 
significant difference was observed between 
urban and rural participants, which is likely 
due to small numbers in the rural cohort. We 
also found higher use of support services 
in female participants, those with higher 
education or younger age (<65 years) or 
those diagnosed with advanced primary 
melanomas (T-stage 4B).
Non-Indigenous Australians residing rurally 
have poorer melanoma survival than those 
residing in urban areas, yet survival does not 
differ between regional and urban patients.16 
Indeed, patients diagnosed with advanced/
metastatic melanoma often re-locate from 
rural areas to larger communities to improve 
access to medical services.19 Migration from 
rural to regional areas also occurs in the 
elderly and/or retired populations,20 and 
this was reflected in our study participants. 
Socioeconomic status including education 
level and employment, was lower among 
regional and rural study participants. This is 
consistent with the lower rate of high school 
completion observed generally in the rural 
population.21,22 Lower levels of educational 
attainment have been linked to greater 
risks in late-stage melanoma diagnosis.23 
Within the restrictions of our cohort however 
(primary invasive melanoma) we did not 
observe a difference in melanoma thickness 
in rural participants. 
The distribution of medical practitioners and 
surgical specialists in Australia favours urban 
areas. In accordance with this distribution 
and the accessibility of GPs, GPs in skin 
cancer clinics and specialist practitioners 
(dermatologists and surgeons), we observed 
that the proportion of melanomas diagnosed 
by either a specialist or skin cancer-specific 
GP was lower in rural areas.24 Frequent 
skin examinations performed by a medical 
practitioner result in increased detection 
of thin melanomas;25,26 we observed that 
urban patients (who received skin checks 
most frequently) were also more commonly 
diagnosed with thinner melanomas. Skin 
examination frequency in rural participants 
was significantly lower which demonstrates 
an important secondary prevention 
discrepancy in this population. 
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of residence. Further research is required to 
identify barriers to support services in rural 
and other vulnerable populations that can be 
removed or modified. We also recommend 
that specialist and primary care physicians 
be encouraged to triage their high-risk 
melanoma patients to support services in 
order to prevent undue distress and optimise 
their mental and physical wellbeing. Early 
engagement with support services would 
also allow early detection of patients 
requiring more intensive psychological or 
physical therapies.
The strengths of these results are their 
being based on a large cohort of primary 
melanomas at high risk of spread, with 
detailed clinical and histological data 
obtained from pathological reports. The 
results do not pertain to melanoma patients 
presenting with nodal or distant metastasis. 
This study had several design limitations. 
Firstly, use of support services was measured 
via a self-reported mail survey and therefore 
was subject to recall bias and variation in 
interpretation of the questions. It likely that 
participants have under-reported their use 
of support services but under-reporting 
and variation in interpretation would be 
uniform across rurality and other subgroups 
of interest. These limitations are therefore 
likely to have had an effect on power in our 
analysis but would not have changed the 
conclusions of our comparisons between 
subgroups. Secondly, although we recruited 
many patients via tertiary referral centres 
which potentially introduced sampling bias, 
many were recruited through primary care 
and indeed we demonstrated comparability 
of the study cohort to melanoma patients 
from the Queensland Cancer Registry within 
the study period.18 Finally, we used the ASCG-
RA remoteness of residence classification 
system whose suitability may be suboptimal 
for areas categorised as ‘rural’, because ‘rural’ 
contains areas such as Townsville and Cairns 
that have melanoma referral centres. Using 
the ASCG-RA classification system is therefore 
likely to under-estimate true ‘rural’ differences 
analysing use of support services.
Conclusion
Use of support services is lower among high-
risk primary melanoma patients who reside 
in rural areas, who are male, elderly or have 
low education, and yet these groups have 
poorer prognosis than others. On the other 
hand patients with T4B more commonly used 
support services compared to those with 
T1B/2A. Melanoma patients are known to 
suffer from poorer psychological wellbeing 
compared to the general population.5 
Appropriate triage to support services is 
required to ensure optimal care.31 Further 
ways to deliver services to rural residents and 
break down the barriers in service uptake 
among these residents as well as other 
vulnerable groups should be identified in 
order to promote emotional and physical 
wellbeing and identify patients in need of 
specialist services.
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